SCHEMBL27426825

SCHEMBL27426825

NC(CC=O)C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A1 P43005 4/20 0.49
▸ SLC1A3 P43003 3/20 0.49
▸ SLC1A2 P43004 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ IDO1 P14902 1/20 0.48
▸ HCAR2 Q8TDS4 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ SLC15A1 P46059 1/20 0.46
▸ LTA4H P09960 1/20 0.46
▸ LAP3 P28838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20349700 1.00 SLC1A1 (0.49) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL27543988 0.88 SLC1A1 (0.44) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL27533978 0.85 ALDH1A1 (0.47) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL8257115 0.85 ALDH1A1 (0.47) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL12873771 0.84 KMT2A (0.49) SLC1A1SLC1A3SLC1A2KMT2AMEN1
Hydrochloric Acid SCHEMBL2528757 0.84 IDO1 (0.46) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL14517178 0.84 KMT2A (0.49) SLC1A1SLC1A3SLC1A2KMT2AMEN1
Hydrochloric Acid SCHEMBL27697735 0.84 IDO1 (0.46) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL24535009 0.83 ALDH1A1 (0.52) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL6649720 0.81 LMNA (0.55) KMT2AALDH1A1IDO1HCAR2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103060396-B A kind of new method for the Atorvastatin calcium for producing high chiral purity 武汉启瑞药业有限公司 2017-09-12 — — CN disclosed
CN-103060396-A Novel method for producing atorvastatin calcium with high chiral purity QR PHARMACEUTICALS LTD 2013-04-24 — — CN disclosed
CN-1112125-A Acyloxyhexanoic acid derivatives CIBA GEIGY AG (CH) 1995-11-22 — — CN disclosed
Send feedback